Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination chemotherapy of advanced non-oat cell carcinoma of the lung.
Richards F 2nd, White DR, Muss HB, Jackson DV, Stuart JJ, Cooper MR, Rhyne L, Spurr CL. Richards F 2nd, et al. Among authors: muss hb. Cancer. 1979 Nov;44(5):1576-81. doi: 10.1002/1097-0142(197911)44:5<1576::aid-cncr2820440506>3.0.co;2-9. Cancer. 1979. PMID: 227571 Clinical Trial. No abstract available.
Combination chemotherapy with and without the methanol-extracted residue of bacillus Calmette-Guerin (MER) in extensive non-small-cell lung cancer: a prospective randomized study for the Piedmont Oncology Association.
Richards F 2nd, Howard V, Shore A, Muss HB, White DR, Jackson DV, Cooper MR, Bearden J, Stuart JJ, Sartiano G, Rhyne AL, Spurr CL. Richards F 2nd, et al. Among authors: muss hb. Cancer. 1981 Jun 15;47(12):2827-32. doi: 10.1002/1097-0142(19810615)47:12<2827::aid-cncr2820471212>3.0.co;2-d. Cancer. 1981. PMID: 6266642 Clinical Trial.
Combination chemotherapy-radiotherapy with and without the methanol-extraction residue of Bacillus Calmette-Guerin (MER) in small cell carcinoma of the lung: a prospective randomized trial of the Piedmont Oncology Association.
Jackson DV Jr, Paschal BR, Ferree C, Richards F 2nd, Muss HB, Cooper MR, White DR, Stuart JJ, Spurr CL, Wells B, Sartiano G, McFarland J, McCulloch J. Jackson DV Jr, et al. Among authors: muss hb. Cancer. 1982 Jul 1;50(1):48-52. doi: 10.1002/1097-0142(19820701)50:1<48::aid-cncr2820500110>3.0.co;2-u. Cancer. 1982. PMID: 6282434 Clinical Trial.
High-dose cyclophosphamide and 5-fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast. A phase III study of the Piedmont Oncology Association (POA).
Zekan PJ, Muss HB, Capizzi RL, Cooper MR, Harding RW, Hopkins JO, Jackson DV, Ramseur WL, Richards F 2nd, Spurr CL, et al. Zekan PJ, et al. Among authors: muss hb. Cancer. 1984 Dec 1;54(11):2338-43. doi: 10.1002/1097-0142(19841201)54:11<2338::aid-cncr2820541105>3.0.co;2-4. Cancer. 1984. PMID: 6388802 Clinical Trial.
Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology Association.
Muss HB, Richards F 2nd, Jackson DV, Cooper MR, White DR, Stuart JJ, Ramseur W, Christian RM, Wells HB, Pope E, Spurr CL. Muss HB, et al. Cancer. 1982 Dec 1;50(11):2269-74. doi: 10.1002/1097-0142(19821201)50:11<2269::aid-cncr2820501107>3.0.co;2-l. Cancer. 1982. PMID: 6754062 Clinical Trial.
476 results